Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Zealand

Rebecca Larcombe,Michael Ward,Kingsley Coulthard,Stephanie Reuter,Vaughn Eaton,Andrew Tai

doi:10.1136/ejhpharm-2022-003545

Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Zealand

Rebecca Larcombe, Michael Ward + Show 4 more

https://doi.org/10.1136/ejhpharm-2022-003545

Copy DOI

Journal: European Journal of Hospital Pharmacy: Science and Practice	Publication Date: Dec 20, 2022
Citations: 2

Affiliation: University of South Australia, Flinders Medical Centre, Women's and Children's Hospital, University of Adelaide

#Therapeutic Drug Monitoring Practice #Cystic Fibrosis Centres + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectivesSophisticated scientific methods have facilitated dose individualisation with substantial advancements in therapeutic drug monitoring (TDM) practice. It is unclear whether these methods have translated to the clinical setting. This study...

Full Text